TBT BSN | Notification

Notification Detail :: G/TBT/N/BDI/458, G/TBT/N/KEN/1577, G/TBT/N/RWA/1000, G/TBT/N/TZA/1102, G/TBT/N/UGA/1914

Notification No.

Notification Type

Notifying Member

Date of Notification

Final Date for Comments

Days to Final Date

Title

DEAS 1198: 2024, Nicotine pouches — Specification, First Edition Note: This Draft East African Standard was also notified under SPS committee

Objective

Protection of human health or safety (TBT); Prevention of deceptive practices and consumer protection (TBT); Protection of animal or plant life or health (TBT); Protection of the environment (TBT); Quality requirements (TBT); Harmonization (TBT); Reducing trade barriers and facilitating trade (TBT); Cost saving and productivity enhancement (TBT); Consumer information, labelling (TBT)

Product Covered

Products containing nicotine, intended for inhalation without combustion (excl. containing tobacco or reconstituted tobacco) (HS code(s): 240412); Tobacco, tobacco products and related equipment (ICS code(s): 65.160)

Document Notification

Link to ePing

HSCODE

240412 - Products containing nicotine, intended for inhalation without combustion (excl. containing tobacco or reconstituted tobacco)

ICSCODE

65.160 - Tobacco, tobacco products and related equipment

Keywords

Specific Regions

Description

This draft East African Standard prescribes the requirements, methods of test and sampling for pre-portioned nicotine pouches exclusively intended for oral use by placing them between the gum and buccal mucosa for a period, to facilitate uptake of the nicotine via the oral mucosa, followed by disposal of the pouch after use.Note: this includes products such as white pouched nicotine products that are used by placing them under the upper lip for a period, before disposal.This draft East African standard does not cover;pre-portioned, tobacco-free oral nicotine pouches in which the nicotine is not of natural origin; smokeless tobacco products, such as moist snuff, tobacco oral pouches, snus, nasal snuff, chewing tobacco or any other tobacco-containing smokeless tobacco products; Nicotine-Containing, Tobacco-Free Oral Products that are licensed medicinal nicotine products, such as nicotine replacement therapies (NRT); products that are subject to an authorization requirement under Directive 2001/83/EC (Community code relating to medicinal products for human use)  or to the requirements set out in Directive 93/42/EEC (Medical Device Directive)  or inhaled-nicotine products, such as cigarettes, other combusted tobacco products, tobacco-heating products or e-cigarettes. method for assessing the health risks or potential reduced health risks of tobacco-free oral nicotine pouches.

Notified Document

1:File here

Link to Notification

EN:File here

Status Active

No	#	Comment By	Title	Comment Date	File

Back

Notification Detail :: G/TBT/N/BDI/458, G/TBT/N/KEN/1577, G/TBT/N/RWA/1000, G/TBT/N/TZA/1102, G/TBT/N/UGA/1914

Link to ePing

App Settings